372. Deputy Pádraig O'Sullivan asked the Minister for Health the number of community pharmacy contractors that have provided notice of participation in Phase 1 of the BowelScreen community pharmacy intervention; the projected cost of the per patient service fee under Phase 2; and if she will make a statement on the matter. [53757/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Pádraig O'Sullivan .
468 questions match, newest first.
373. Deputy Pádraig O'Sullivan asked the Minister for Health the number of community pharmacy contractors in receipt of the emergency medicine administration preparedness allowance introduced under the Community Pharmacy Agreement 2025; the number of recorded administrations of naloxone in community settings in 2025; and if she will make a statement on the matter. [53758/26]
374. Deputy Pádraig O'Sullivan asked the Minister for Health the current operational status of the medically supervised injecting facility following the conclusion of its pilot phase in June 2026; when the final evaluation and child impact assessment due in the fourth quarter of 2026 will be published; and if she will make a statement on the matter. [53759/26]
375. Deputy Pádraig O'Sullivan asked the Minister for Health whether her Department has assessed the case for mandatory folic acid fortification of staple foods, in view of Ireland's rates of neural tube defects remaining among the highest in Europe; and if she will make a statement on the matter. [53760/26]
795. Deputy Pádraig O'Sullivan asked the Minister for Health when the multidisciplinary team (MDT) meeting will take place between CUH, UHL and CAMHS Limerick under the new autism rules and the National Autism Innovation Strategy, for a case involving suspected autistic catatonia; to list the statutory rights and obligations that require these services to share information quickly (details supplied); the exact time…
851. Deputy Pádraig O'Sullivan asked the Minister for Health the number of patients availing of the GMS medicines optimisation support service since its commencement on 1 June 2026; the number of patients previously in receipt of phased dispensing who have transitioned to the new service; and if she will make a statement on the matter. [53324/26]
852. Deputy Pádraig O'Sullivan asked the Minister for Health the projected full-year cost of the GMS medicines optimisation support service, including the €0.35 fee payable per GMS item dispensed and the €32.50 monthly enhanced medicines optimisation support fee, as agreed under the Community Pharmacy Agreement 2025; the amount paid out under each fee to date in 2026; and if she will make a statement on the matter. […
853. Deputy Pádraig O'Sullivan asked the Minister for Health if she will publish the PCRS-approved list of medicines that qualify a patient for the enhanced medicines optimisation support fee under the GMS medicines optimisation support service; the clinical criteria used to compile that list; whether the list will be kept under review; and if she will make a statement on the matter. [53326/26]
854. Deputy Pádraig O'Sullivan asked the Minister for Health the eligibility criteria applying to the GMS medicines optimisation support service for patients with cognitive or physical impairment, intellectual disability, or experiencing social exclusion including homelessness; the method by which eligibility is assessed and by whom; the appeal mechanism available where a patient is refused access; and if she will ma…
855. Deputy Pádraig O'Sullivan asked the Minister for Health the rationale for treating monitored dosage systems, commonly known as blister packs, as a last-resort option under the GMS medicines optimisation support service which commenced on 1 June 2026; her response to concerns that patients in residential care settings will no longer receive blister packs free of charge; the assessment her Department has carried o…
856. Deputy Pádraig O'Sullivan asked the Minister for Health whether patients in receipt of free phased dispensing or blister packs in August 2025 will retain that support indefinitely under the GMS medicines optimisation support service; the arrangements for new patients who would previously have qualified; and if she will make a statement on the matter. [53329/26]
857. Deputy Pádraig O'Sullivan asked the Minister for Health the number of community pharmacies onboarded to date to the national unused medicines return and disposal scheme provided for under the Community Pharmacy Agreement 2025; the target date for all pharmacies to be participating; and if she will make a statement on the matter. [53333/26]
858. Deputy Pádraig O'Sullivan asked the Minister for Health the reason Ireland did not operate a national collection system for unused medicines despite the obligation under Directive 2004/27/EC, in place since 2004; the steps taken to ensure the new scheme achieves full compliance with that Directive; and if she will make a statement on the matter. [53334/26]
859. Deputy Pádraig O'Sullivan asked the Minister for Health when the planned public awareness campaign on the return of unused medicines to pharmacies will launch; the budget allocated to that campaign; and if she will make a statement on the matter. [53335/26]
860. Deputy Pádraig O'Sullivan asked the Minister for Health whether the review of the national unused medicines return and disposal scheme scheduled after nine months of operation will be published; the metrics that will be used to evaluate the scheme, including tonnage of medicines collected and pharmacy participation rates; and if she will make a statement on the matter. [53336/26]
861. Deputy Pádraig O'Sullivan asked the Minister for Health the assessment her Department has made of the contribution of unused medicines in the home to accidental poisoning of children, self-harm and suicide risk; whether data on hospital presentations linked to accidental ingestion of medicines by children will be used to evaluate the impact of the national unused medicines return scheme; and if she will make a s…
862. Deputy Pádraig O'Sullivan asked the Minister for Health whether she will bring forward proposals to control nitrous oxide under the Misuse of Drugs Act 1977, in view of the hospital discharge data for 2020 to 2024 showing a rise in neurological presentations linked to recreational nitrous oxide use, with a mean patient age of 19.7 years; and if she will make a statement on the matter. [53338/26]
863. Deputy Pádraig O'Sullivan asked the Minister for Health the number of people who entered treatment for problem nitrous oxide use in each of the years from 2021 to 2025; the number in each year aged 17 years or under; the services available specifically for adolescents presenting with nitrous oxide-related harm; and if she will make a statement on the matter. [53339/26]
864. Deputy Pádraig O'Sullivan asked the Minister for Health whether the HSE has issued clinical guidance to emergency departments and neurology services on the recognition and treatment of nitrous oxide-induced neurological injury, including subacute combined degeneration of the spinal cord; and if she will make a statement on the matter. [53340/26]
865. Deputy Pádraig O'Sullivan asked the Minister for Health whether her Department has examined restricting the sale of flavoured nitrous oxide canisters marketed towards young people; and if she will make a statement on the matter. [53341/26]
885. Deputy Pádraig O'Sullivan asked the Minister for Health the annual cost of the national unused medicines return and disposal scheme; the details of the contract awarded to the appointed waste disposal provider including its duration and value; whether the contract was subject to competitive tender; and if she will make a statement on the matter. [53451/26]
784. Deputy Pádraig O'Sullivan asked the Minister for Health further to the HSE’s confirmation that all clinical sites have been required to verify compliance with the public only consultant contract, the number of hospital sites that have returned compliance confirmations to date; the number that remain outstanding; whether the results will be published by hospital group, region or site; and if she will make a state…
785. Deputy Pádraig O'Sullivan asked the Minister for Health the assessment that has been carried out of consultant obstetrician and gynaecologist staffing levels and midwifery staffing levels in Irish maternity services compared with international benchmarks; whether the next National Maternity Strategy will include specific staffing and continuity-of-care targets; and if she will make a statement on the matter. [51…
871. Deputy Pádraig O'Sullivan asked the Minister for Health further to the estimate in the National Rare Disease Strategy 2025-2030 that 300,000 people in Ireland live with a rare disease, whether her Department or the Health Service Executive holds data on the breakdown of these conditions by disease or disease category; the status of the National Rare Disease Registry recommended in the Strategy; and if she will m…
872. Deputy Pádraig O'Sullivan asked the Minister for Health the number of rare disease conditions affecting patients in Ireland for which a licensed treatment or medicine is available; the number for which no treatment exists, as recorded by her Department, the Health Service Executive or the National Rare Diseases Office; and if she will make a statement on the matter. [51877/26]